Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2017 Mar 6;5:27. doi: 10.1186/s40425-017-0221-x

Erratum to: Metastatic Merkel cell carcinoma response to nivolumab

Frances M Walocko 1, Benjamin Y Scheier 2, Paul W Harms 3,4, Leslie A Fecher 2, Christopher D Lao 2,
PMCID: PMC5340072  PMID: 28286652

Erratum

Following publication of this article [1], it was noticed that the Clinical Trial Number in the last paragraph of the conclusions section was incorrectly listed as NCT02155647. The correct Clinical Trials Number is NCT02488759.

Footnotes

The online version of the original article can be found under doi:10.1186/s40425-016-0186-1.

Reference

  • 1.Walocko FM, Scheier BY, Harms PW, Fecher LA, Lao CD. Metastatic Merkel cell carcinoma response to nivolumab. J Immunother Cancer. 2016;4:79. doi: 10.1186/s40425-016-0186-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES